Today: 29 April 2026
Browse Category

Investment Opportunities 24 September 2025 - 7 November 2025

Momentum (MMT) News Today — Nov 7, 2025: Bybit’s 400,000‑MMT Megadrop Live, Bitget Spot Listing This Week, OKX $1M Flash‑Earn Window Closes; Fresh Price Outlook

Momentum (MMT) News Today — Nov 7, 2025: Bybit’s 400,000‑MMT Megadrop Live, Bitget Spot Listing This Week, OKX $1M Flash‑Earn Window Closes; Fresh Price Outlook

OKX’s Flash Earn airdrop for MMT ends today, capping a three-day event distributing 1,000,000 tokens. Bybit’s Megadrop campaign remains open until Nov 10, offering a 400,000-MMT prize pool. Bitget and Binance both listed MMT this week. MMT price trades well below its Nov 4 all-time high amid high volume and volatility.
7 November 2025
Is ALAR Stock the Next AI Goldmine? Discover Alarum’s Explosive Run and What Analysts Are Saying

Is ALAR Stock the Next AI Goldmine? Discover Alarum’s Explosive Run and What Analysts Are Saying

Alarum Technologies (NYSE: ALAR) closed at $16.25 on Nov. 3, up roughly 55% year-to-date and about 150% in the past six months. Q2 2025 revenue reached $8.8 million with net profit at $0.3 million. The company forecasts Q3 revenue of $12.8 million, boosted by a new $3 million AI-data contract. Analyst consensus is bullish, with targets averaging $22; shares trade above key moving averages.
Starting a Business in Ukraine in 2025: 10 Crucial Facts Every Entrepreneur Must Know

Ukraine’s 2025 Post-War Comeback: Booming Industries, Big Investments & Hidden Opportunities

Russia’s invasion has caused $176 billion in damage to Ukraine, with reconstruction needs estimated at $524 billion over the next decade, according to the World Bank and UN. Ukraine’s GDP rebounded 5% in 2023 after a 30% collapse in 2022, but foreign investment fell 25% in 2024. Inflation remains high and budget deficits are large. The IT sector remains resilient, while agriculture faces major losses and export challenges.
31 October 2025
Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics shares soared 206% to close at $1.07 on October 27 after announcing a joint venture with Arabian Eagle Manufacturing to distribute PCR tests in Saudi Arabia and 18 other countries. Over 100 million shares traded amid the surge. The stock’s market cap jumped from about $18 million to as much as $60 million. The company reported just $200,000 in Q2 revenue and recently raised $3.8 million via stock sale.
Energy Stock on Fire: EPD’s 7% Yield and Massive Growth Plans Might Be About to Spark a Rally

Energy Stock on Fire: EPD’s 7% Yield and Massive Growth Plans Might Be About to Spark a Rally

Enterprise Products Partners declared a $0.545 per unit Q3 distribution in October 2025, marking its 27th consecutive annual payout increase. Shares trade near $31, with analysts’ average 12-month target at $35.8 and most rating it a “Buy.” Q2 distributable cash flow rose about 7% to $1.8 billion, covering payouts by 1.6 times. EPD continues major growth projects and repurchased $80 million in units during Q3.
Quantum Gold Rush: D-Wave (QBTS) Stock Rockets on Government Funding Hopes and Breakthrough Deals

Quantum Gold Rush: D-Wave (QBTS) Stock Rockets on Government Funding Hopes and Breakthrough Deals

D-Wave’s share price surged nearly 3,000% in the past year, peaking at $46.75 on Oct. 15 before dropping to $27.30 and rebounding to $31.06 after reports of possible U.S. government equity deals with quantum firms. The company announced a €10 million sale of its Advantage2 system in Europe and posted first-half 2025 revenue of $18 million against a Q2 GAAP loss of $167 million. Trading volumes remain extremely high.
SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi Stock Skyrockets 230% in 2025 as Earnings Loom – $1.6 Trillion Opportunity Sparks Frenzy

SoFi Technologies shares have surged about 230% in the past year, recently trading near $28.80 and approaching a 52-week high. The company will report Q3 earnings on Oct. 28, with Wall Street expecting $880 million in revenue and EPS of $0.08. SoFi has expanded its platform with new trading products, an AI ETF, and a partnership for blockchain money transfers. Policy changes on federal student loans have boosted refinancing activity.
Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa shares closed at $37.13, with analyst 12-month targets ranging from $42 to $65. The US and Australian governments agreed to fund a gallium plant at Alcoa’s Wagerup refinery, aiming for 100 metric tons per year. Alcoa warned US aluminum tariffs could cut Q3 results by $90 million. The company will hold an Investor Day at the NYSE on Oct. 30.
AI Boom’s Hidden Gem: Credo (CRDO) Stock Soars on $500 “Purple” Cables and Big Partnerships

AI Boom’s Hidden Gem: Credo (CRDO) Stock Soars on $500 “Purple” Cables and Big Partnerships

Credo’s stock doubled in 2025, reaching around $143 after a 245% jump in 2024, fueled by soaring demand for its AI data center gear. Fiscal 2025 revenue hit $436.8 million, with net profit at $52.2 million. The company unveiled new 1.6Tbps cables and joined Arm’s AI chip ecosystem in October. CRDO’s market cap stands near $25–26 billion, with JPMorgan rating it Overweight despite high volatility.
USA Rare Earth’s Meteoric Rise: The Pre-Revenue Mining Stock Targeting $30+ amid China Tensions

USA Rare Earth’s Meteoric Rise: The Pre-Revenue Mining Stock Targeting $30+ amid China Tensions

USA Rare Earth shares surged over 120% year-to-date, closing at $32.61 on Oct. 13 after CEO Barbara Humpton disclosed White House talks and a $100 million deal to acquire UK-based Less Common Metals. The company, still pre-revenue, reported a Q2 net loss of $142.7 million and held $121.8 million cash as of June 30, with analysts split on its soaring valuation.
Protagonist Therapeutics (PTGX) Skyrockets on J&J Buyout Buzz Amid Clinical Breakthroughs

Protagonist Therapeutics (PTGX) Skyrockets on J&J Buyout Buzz Amid Clinical Breakthroughs

Protagonist Therapeutics shares surged over 30% to $89.19 on Oct. 10, 2025, after reports that Johnson & Johnson is in talks to acquire the company. Trading was briefly halted due to volatility. The jump follows positive Phase 2b results for Icotrokinra in ulcerative colitis and recent FDA Breakthrough Therapy Designation for Rusfertide in polycythemia vera.
Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Why Intellia Therapeutics’ Stock Could Be a Gene‑Editing Goldmine in 2025 – Deep Dive into NTLA’s Prospects

Intellia shares surged to $26.14 on Oct. 8, up 72.6% over the past month, after Phase 1 data showed its CRISPR therapy reduced serum TTR by 92% at 24 months. The company reported Q2 revenue of $14.2 million and a narrowed net loss per share of $0.98. Cash reserves stood at $630 million. Analyst consensus rates the stock a “Moderate Buy” with targets averaging $27–34.
DVLT Just Landed a $150M Bitcoin Lifeline — Can Datavault AI Turn a Penny Stock Into an AI Supercomputer?

DVLT Just Landed a $150M Bitcoin Lifeline — Can Datavault AI Turn a Penny Stock Into an AI Supercomputer?

Datavault AI signed a $150 million Bitcoin-funded investment deal with Scilex Holding, split into two tranches. The first $8.067 million is set to close Sept. 26, with the remaining $141.933 million pending shareholder approval due to Nasdaq rules. Scilex will receive up to 278.9 million DVLT shares and board nomination rights. DVLT stock jumped over 28% on Sept. 25 and rose further in pre-market trading.
Peabody Energy’s 2025 Coal Comeback: Big Buybacks, Booming Demand, and a Surging Stock

Peabody Energy’s 2025 Coal Comeback: Big Buybacks, Booming Demand, and a Surging Stock

Peabody Energy shares jumped nearly 8% on September 24, closing around $25.71, and are up about 30–35% over the past quarter. The company canceled a $3.8 billion deal for Anglo American’s Australian coal assets in August after a mine fire. Peabody raised full-year guidance despite a Q2 loss and expanded its $1 billion buyback. Analyst price targets have climbed to $23–$24 as coal demand stays strong.

Stock Market Today

  • Franco-Nevada (TSX:FNV) Valuation Review Amid Share Price Decline
    April 28, 2026, 11:11 PM EDT. Franco-Nevada (TSX:FNV) shares have fallen 3.2% in one day and 6.1% over a week, triggering reassessment of its valuation. Despite a 12.5% drop over 90 days, the stock still shows an 11.2% gain year-to-date and 37.2% total return over one year, revealing fading short-term momentum but solid long-term growth. Shares trade at CA$318.05, below analyst targets near CA$402.66 and a fair value estimate of CA$388.82, indicating an 18.2% undervaluation. Ongoing acquisitions of high-quality gold assets diversify risk and enhance growth potential. However, the 40.3 times price-to-earnings ratio exceeds industry and peer averages, suggesting valuation risk if gold markets weaken or key projects face issues. Investors should weigh growth forecasts against these risks before positioning on Franco-Nevada.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

29 April 2026
Oracle shares fell 4% and CoreWeave dropped 5.9% Tuesday after a Wall Street Journal report said OpenAI missed recent revenue and user targets. Nvidia, AMD, and Arm Holdings also declined, with the iShares Semiconductor ETF down 3.7%. OpenAI denied internal divisions and said its AI coding product Codex reached 4 million users. Oracle’s credit default swaps hit a two-week high amid concern over its $300 billion cloud deal with OpenAI.
Go toTop